Ligand Pharmaceuticals | Fremdkapital



Loan Capital Veränderung Datum
Amgen USD 56.55B 305M 2024-12
Arrowhead Research USD 407.79M 14.61M 2024-12
Baxter International USD 10.37B 63M 2024-12
Bristol-Myers Squibb USD 47.6B 1.07B 2024-12
Eli Lilly USD 28.53B 518.3M 2024-12
Gilead Sciences USD 24.9B 3.46B 2024-12
GlaxoSmithKline GBP 14.64B 1.39B 2024-12
Glaxosmithkline GBP 14.64B 1.39B 2024-12
Insmed USD 1.13B 147.77M 2024-12
Ionis Pharmaceuticals USD 1.25B 11.67M 2024-12
Ligand Pharmaceuticals USD 0 0 2024-12
MacroGenics USD 0 0 2024-12
Merck USD 34.46B 520M 2024-12
Pacira USD 383.54M 2.35M 2024-12
Pfizer USD 57.4B 597M 2024-12
Veracyte USD 0 100K 2024-12



Ligand Pharmaceuticals Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.